InterCure to Participate in Canaccord Genuity’s 8th Annual Global Cannabis Conference

Rhea-AI Summary

InterCure (NASDAQ: INCR, TASE: INCR), also known as Canndoc, announced its participation in the Canaccord Genuity 8th Annual Global Cannabis Conference. Scheduled for May 23, 2024, at the Westin NY Grand Central Hotel in New York City, the event will feature senior management teams from leading cannabis companies. InterCure's CEO, Alex Rabinovitch, will take part in panel discussions, fireside chats, and one-on-one meetings. The conference aims to foster engagement and share insights among industry leaders.

Positive

• InterCure's participation in a prestigious industry event could enhance its visibility and credibility.
• CEO Alex Rabinovitch's involvement in discussions and meetings may lead to valuable networking opportunities and potential partnerships.

Negative

• No financial data or clinical results were disclosed, limiting the assessment of InterCure's current performance.
• The event participation alone does not guarantee any immediate business gains or stock performance improvements.

NEW YORK & HERZLIYA, Israel--(BUSINESS WIRE)-- InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc), the leading medical cannabis company outside of North America, today announced that it will participate in the Canaccord Genuity 8th Annual Global Cannabis Conference. The conference is scheduled for tomorrow, May 23, 2024, at the Westin NY Grand Central Hotel in New York City.

This prestigious event will bring together senior management teams from leading cannabis companies including InterCure CEO Alex Rabinovitch, to engage in panel discussions, fireside chats, and one-on-one meetings. For more information about the event please refer to the following link:

https://www.canaccordgenuity.com/capital-markets/events-and-conferences/cg-8th-annual-global-cannabis-conference/

About InterCure (dba Canndoc)
InterCure (dba Canndoc) (NASDAQ: INCR) (TASE: INCR) is the leading, profitable, and fastest growing cannabis company outside of North America. Canndoc, a wholly owned subsidiary of InterCure, is Israel’s largest licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products. InterCure leverages its market leading distribution network, best in class international partnerships and a high-margin vertically integrated "seed-to-sale" model to lead the fastest growing cannabis global market outside of North America.

For more information, visit: http://www.intercure.co.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240522762595/en/

InterCure Ltd.

Amos Cohen, Chief Financial Officer

amos@intercure.co

Source: InterCure Ltd.

FAQ

What is the date of the Canaccord Genuity 8th Annual Global Cannabis Conference?

The conference is scheduled for May 23, 2024.

Which company announced its participation in the Canaccord Genuity Global Cannabis Conference?

InterCure (NASDAQ: INCR, TASE: INCR) announced its participation.

Who from InterCure will participate in the Canaccord Genuity Global Cannabis Conference?

InterCure CEO Alex Rabinovitch will participate in the conference.

Where is the Canaccord Genuity 8th Annual Global Cannabis Conference held?

The conference will be held at the Westin NY Grand Central Hotel in New York City.